BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 25510165)

  • 1. Short- and long-term outcomes after silastic medicalization laryngoplasty: are arytenoid procedures needed?
    Benninger MS; Manzoor N; Ruda JM
    J Voice; 2015 Mar; 29(2):236-40. PubMed ID: 25510165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Endoscopic Arytenoid Medialization for Unilateral Vocal Fold Paralysis.
    Rovó L; Ambrus A; Tóbiás Z; Wootten CT; Bach Á
    Laryngoscope; 2021 Mar; 131(3):E903-E910. PubMed ID: 32790084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the Voice Handicap Index for Patients With Unilateral Vocal Fold Paralysis Who Underwent Arytenoid Adduction.
    Watanabe K; Sato T; Honkura Y; Kawamoto-Hirano A; Kashima K; Katori Y
    J Voice; 2020 Jul; 34(4):649.e1-649.e6. PubMed ID: 30616964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approach of medialization thyroplasty with arytenoid adduction performed under general anesthesia with a laryngeal mask.
    Stow NW; Lee JW; Cole IE
    Otolaryngol Head Neck Surg; 2012 Feb; 146(2):266-71. PubMed ID: 22075075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term treatment results for unilateral vocal fold palsy induced by mediastinal lesions.
    Lee YS; Kim YH; Kwon M; Ryu IS; Jung GE; Kim ST; Roh JL; Choi SH; Kim SY; Nam SY
    J Voice; 2014 Nov; 28(6):809-15. PubMed ID: 25008380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voice outcomes following medialization laryngoplasty with and without arytenoid adduction.
    Zimmermann TM; Orbelo DM; Pittelko RL; Youssef SJ; Lohse CM; Ekbom DC
    Laryngoscope; 2019 Aug; 129(8):1876-1881. PubMed ID: 30582612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medialization Laryngoplasty After Injection Augmentation.
    Silva Merea V; Husain S; Sulica L
    J Voice; 2018 Mar; 32(2):249-255. PubMed ID: 28684252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of pitch range after arytenoid adduction by fenestration approach combined with type I thyroplasty for unilateral vocal fold paralysis.
    Tokashiki R; Hiramatsu H; Shinada E; Motohashi R; Nomoto M; Toyomura F; Suzuki M
    J Voice; 2012 Nov; 26(6):792-6. PubMed ID: 22417985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arytenoid adduction combined with medialization laryngoplasty under general anesthesia using a laryngeal mask airway.
    Kanazawa T; Watanabe Y; Hara M; Shinnabe A; Kusaka G; Murayama T; Iino Y
    Am J Otolaryngol; 2012; 33(3):303-7. PubMed ID: 21962288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arytenoid adduction combined with nerve-muscle pedicle flap implantation or type I thyroplasty.
    Kodama N; Kumai Y; Sanuki T; Yumoto E
    Laryngoscope; 2017 Jan; 127(1):159-166. PubMed ID: 27112111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laryngoplasty with hyaluronic acid in patients with unilateral vocal fold paralysis.
    Reiter R; Brosch S
    J Voice; 2012 Nov; 26(6):785-91. PubMed ID: 22578435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arytenoid vertical height discrepancy in predicting outcomes after unilateral vocal cord medialization.
    Wong E; Smith M; Stone DB; Palme CE; Smith MC; Riffat F
    Laryngoscope; 2020 Feb; 130(2):418-422. PubMed ID: 30843620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection versus medialization laryngoplasty for the treatment of unilateral vocal fold paralysis: follow-up at six months.
    Vinson KN; Zraick RI; Ragland FJ
    Laryngoscope; 2010 Sep; 120(9):1802-7. PubMed ID: 20641088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Sequentially Combined Arytenoid Adduction and Injection Laryngoplasty in Patients With Unilateral Vocal Fold Paralysis.
    Choi N; Kim Y; Song BH; Koh SM; Park W; Kim HJ; Son YI
    J Voice; 2022 Nov; 36(6):868-873. PubMed ID: 33097366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of pitch range evaluation subsequent to arytenoid adduction and thyroplasty.
    Konomi U; Watanabe Y; Komazawa D
    J Voice; 2014 May; 28(3):394.e5-12. PubMed ID: 24345604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of medialization laryngoplasty with and without arytenoid adduction.
    Chang J; Schneider SL; Curtis J; Langenstein J; Courey MS; Yung KC
    Laryngoscope; 2017 Nov; 127(11):2591-2595. PubMed ID: 28699172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of temporary vocal fold injection medialization on the rate of permanent medialization laryngoplasty in unilateral vocal fold paralysis patients.
    Yung KC; Likhterov I; Courey MS
    Laryngoscope; 2011 Oct; 121(10):2191-4. PubMed ID: 21898421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Custom implants for medialization laryngoplasty: a model that considers tissue compression.
    Benninger MS; Chota RL; Bryson PC; Drake RL
    J Voice; 2015 May; 29(3):363-9. PubMed ID: 25920766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term voice outcomes of laryngeal framework surgery for unilateral vocal fold paralysis.
    Mes SD; Hendriksma M; Heijnen BJ; Goudsmit BFJ; Jansen JC; Langeveld APM; Sjögren EV
    Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):1957-1965. PubMed ID: 34787700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection laryngoplasty outcomes in irradiated and nonirradiated unilateral vocal fold paralysis.
    Chang J; Courey MS; Al-Jurf SA; Schneider SL; Yung KC
    Laryngoscope; 2014 Aug; 124(8):1895-9. PubMed ID: 24473831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.